IGH/BCL2 Status Better Predicts Clinico-Pathological Behavior in Primary Splenic Follicular Lymphoma than Histological Grade and Other Molecular Markers.

Verghese, Cherian; Li, Weihong; Gvazava, Nanuli; Alimpertis, Emmanouil; Kahlon, Navkirat; Sun, Hongliu; Booth, Robert

Verghese, Cherian; Li, Weihong; Gvazava, Nanuli; Alimpertis, Emmanouil; Kahlon, Navkirat; Sun, Hongliu; Booth, Robert.

Afiliación

Verghese C; Division of Hematology & Oncology, University of Missouri, Columbia, MO, USA.
Li W; Department of Pathology, University of Toledo College of Medicine, Toledo, OH, USA.
Gvazava N; Department of Medicine, University of Missouri, Columbia, MO, USA.
Alimpertis E; Division of Hematology & Oncology, Advocate Aurora Health Inc, Marinette, WI, USA.
Kahlon N; Division of Hematology & Oncology, University of Toledo College of Medicine & Life Sciences, Toledo, OH, USA.
Sun H; Division of Pathology, Firelands Regional Medical Center, Sandusky, OH, USA.
Booth R; Division of Pathology, University of Toledo- Health Sciences Campus, Toledo, OH, USA.

Clin Pathol ; 15: 2632010X221129242, 2022.

Article en En | MEDLINE | ID: mdl-36313587

Palabras clave

Lymphoma; florescence in situ hybridization; immunohistochemistry; molecular pathology

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Pathol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google